SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (389)9/6/1996 1:20:00 PM
From: richard davis   of 4342
 
I am unfamilar with the process. Did PRLN choose Bastyr University or did the FDA? I agree with your concern over the University and its credentials. I am also interested with how David Cohen fits into this picture, he seems to be supporting the PRLN355 compound.

With 27,1, that compound is currently in "compassionate" testing. Does anyone know, if that compound is successful in this testing phase, will it also be given the fast track for approval by FDA?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News